Credit Suisse’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $793K | Buy |
35,809
+1,759
| +5% | +$39K | ﹤0.01% | 2396 |
|
|
2023
Q4 | $735K | Buy |
34,050
+4,598
| +16% | +$99.2K | ﹤0.01% | 2529 |
|
|
2023
Q3 | $497K | Sell |
29,452
-1,462
| -5% | -$24.7K | ﹤0.01% | 2687 |
|
|
2023
Q2 | $424K | Buy |
30,914
+3,124
| +11% | +$42.9K | ﹤0.01% | 2856 |
|
|
2023
Q1 | $631K | Buy |
27,790
+4,618
| +20% | +$105K | ﹤0.01% | 2595 |
|
|
2022
Q4 | $545K | Buy |
23,172
+7,233
| +45% | +$170K | ﹤0.01% | 2715 |
|
|
2022
Q3 | $416K | Buy |
15,939
+276
| +2% | +$7.2K | ﹤0.01% | 2879 |
|
|
2022
Q2 | $345K | Buy |
15,663
+799
| +5% | +$17.6K | ﹤0.01% | 3063 |
|
|
2022
Q1 | $667K | Buy |
14,864
+1,706
| +13% | +$76.6K | ﹤0.01% | 2794 |
|
|
2021
Q4 | $564K | Buy |
13,158
+365
| +3% | +$15.6K | ﹤0.01% | 2946 |
|
|
2021
Q3 | $851K | Buy |
12,793
+798
| +7% | +$53.1K | ﹤0.01% | 2686 |
|
|
2021
Q2 | $879K | Sell |
11,995
-589
| -5% | -$43.2K | ﹤0.01% | 2718 |
|
|
2021
Q1 | $862K | Buy |
12,584
+314
| +3% | +$21.5K | ﹤0.01% | 2662 |
|
|
2020
Q4 | $823K | Buy |
12,270
+2,956
| +32% | +$198K | ﹤0.01% | 2689 |
|
|
2020
Q3 | $479K | Buy |
+9,314
| New | +$479K | ﹤0.01% | 2707 |
|